Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26767402)
Watch
English
Clinical Overview of MDM2/X-Targeted Therapies
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
review article
1 reference
stated in
Europe PubMed Central
title
Clinical Overview of MDM2/X-Targeted Therapies
(English)
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
author
Andrew Burgess
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
Keeming Chia
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
David M Thomas
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
Elgene Lim
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
author name string
Sue Haupt
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
Ygal Haupt
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
language of work or name
English
0 references
publication date
27 January 2016
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
published in
Frontiers in Oncology
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
volume
6
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
page(s)
7
1 reference
stated in
Europe PubMed Central
PMCID
4728205
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26858935%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
cites work
Mdm2 promotes the rapid degradation of p53
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Regulation of p53 stability by Mdm2
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Hdmx modulates the outcome of p53 activation in human tumor cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Complex structure and regulation of the P16 (MTS1) locus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
A novel p16INK4A transcript
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
MDM2 and MDMX: Alone and together in regulation of p53
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Restoration of p53 function leads to tumour regression in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
p53 ubiquitination: Mdm2 and beyond
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
7 April 2017
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Identifying the determinants of response to MDM2 inhibition.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Limiting the power of p53 through the ubiquitin proteasome pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Mutant p53 reactivation by small molecules makes its way to the clinic.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Drugging the p53 pathway: understanding the route to clinical efficacy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
MDM2, MDMX and p53 in oncogenesis and cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Transcriptional Regulation of the p53 Tumor Suppressor Gene in S-Phase of the Cell-Cycle and the Cellular Response to DNA Damage
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
p53 regulation by ubiquitin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Two-phase dynamics of p53 in the DNA damage response.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
A small-molecule inhibitor of MDMX activates p53 and induces apoptosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Posttranslational modification of p53: cooperative integrators of function
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Identification and characterization of the first small molecule inhibitor of MDMX
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Ubiquitin-independent p53 proteasomal degradation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Modeling the therapeutic efficacy of p53 restoration in tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Apoptosis - the p53 network
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728205
retrieved
28 September 2017
Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFONC.2016.00007
retrieved
21 January 2018
Not all p53 gain-of-function mutants are created equal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFONC.2016.00007
retrieved
21 January 2018
Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFONC.2016.00007
retrieved
21 January 2018
Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26858935
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.3389/FONC.2016.00007
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/v4rrv6dy3rgdvowk6ticlozcey
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
Fatcat ID
release_v4rrv6dy3rgdvowk6ticlozcey
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/v4rrv6dy3rgdvowk6ticlozcey
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
PMCID
4728205
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/v4rrv6dy3rgdvowk6ticlozcey
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
PubMed ID
26858935
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/v4rrv6dy3rgdvowk6ticlozcey
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
ResearchGate publication ID
291997750
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit